Pharmaceutical Industry

Obesity is linked to lower steroid-free clinical remission rates in patients with inflammatory bowel disease, a recent study reveals.

Swiss group becomes latest pharmaceutical company to promise investment in the face of potential tariffs

Health news and commentary gathered by MedPage Today staff

The use of healthcare services for the long-term management of IBD is less prevalent among historically marginalized racial and ethnic groups than among White American individuals.

On April 19, 1943, Albert Hofmann, a chemist working at the Swiss pharmaceutical company Sandoz, swallowed 240 micrograms of lysergic acid diethylamide (LSD) and had the first intentional acid trip…

Scientists discovered two genes involved in hyperemesis gravidarum, a condition that can cause extreme nausea and vomiting during pregnancy. Now they're looking into treatments

Albuminuria screening in patients at risk for CKD in primary care, when combined with standard opportunistic screening, shows a satisfactory participation rate and effectiveness when conducted by GPs.

Trump has repeatedly said the United States is taking in $2 billion per day from tariffs.

Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, a Reuters review of Chinese regulator data...

'The very first time we have identified a treatment that is effective for this form of MS'

U.S. President Donald Trump on Sunday said he would be announcing the tariff rate on imported semiconductors over the next week, adding that there would be flexibility with some companies in the sector.

A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS.

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and other drugs.

Novo Nordisk and Sanofi were among the companies threatening to hasten their exits to the U.S., as Trump promised pharma tariffs were coming "shortly."

As the cost of weight-loss drugs skyrockets, state Medicaid programs are looking for ways to cover the rising costs.

Saturday's protests were a show of force and solidarity for those opposed to President Donald Trump's policies. But it may take more than rallies to change things.

/PRNewswire-PRWeb/ -- Homin Lee, shareholder of global law firm Greenberg Traurig, LLP, was again named a 2025 Banking and Finance Visionary by the Los Angeles...

China wants investors but only in sectors it chooses.

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.

Getting vaccinated against shingles may not only lower risk for the condition — it may offer some protection against dementia, a new study suggests.